Review

Is radical cystectomy the gold standard?

• Binhan Kağan Aktaş
• Ali Memiş

The Risk Stratifications in Non-Muscle Invasive Bladder Cancer: How Much Accurate are the Methods That We Use? A Multi-Directional View

• Barış Kuzgunbay
• Yıldırım Bayazıt

Is intravesical BCG treatment necessary and/or sufficient?

• Sinan Ekici
• Polat Türker

Non-Muscle Invasive Bladder Cancer: Diagnosis and Treatment of Highest-Risk Subgroup

• Yılören Tanıdır
• İlker Tınay

Can Bladder be Preserved with TURB + Chemotherapy instead of Radical Surgery (Can we Preserve the Bladder from Cancer)

• Cavit Can

Neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer

• Aziz Karaoğlu
• Utku Oflazoğlu
• Necla Demir

Role of Nanoparticles in the Treatment of Noninvasive Bladder Cancer

• Erem Bilensoy
• Nazlı Erdoğar
• Aydın N. Mungan

Which Treatment Should We Prefer for High-Risk Nonmuscle Invasive Bladder Cancer? Early Cystectomy or Bladder Sparing?

• Ali Furkan Batur
• Sinan Sözen

The Approach to High Risk Bladder Cancers in The Absence of Bacillus Calmette Guérin: What should Be the Treatment and Follow Up?

• Polat Türker
• Levent Türkeri

Hexyl Aminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis of Patients with Non-Muscle Invasive Bladder Cancer: A Review Based on Meta-Analysis

• Emre Tüzel

Original Article

Predicting Lamina Propria Invasion in Patients with Nonmuscle- invasive Bladder Cancer: Do RDW and NLR Really Work?

• Aykut Buğra Şentürk
• Musa Ekici
• Cemil Aydın
• Mehmet Murat Baykam
• Tuncay Taş
• Ersan Arda
• Basri Çakıroğlu

Prognostic Values of Inflammatory Markers in Patients with High-grade Lamina Propria-invasive Bladder Cancer

• İsmail Önder Yılmaz
• Mutlu Değer
• Nebil Akdoğan
• İbrahim Atilla Arıdoğan
• Yıldırım Bayazıt
• Volkan İzol

5-Hydroxyuracil Incision Activity Varies According to the Histological Grade of Non-muscle-invasive Bladder Cancer

• Selçuk Keskin
• Fatma Merve Antmen
• Berna Somuncu
• Yeşim Sağlıcan
• Tünkut Doğanca
• Can Öbek
• Ümit İnce
• Ali Rıza Kural
• Meltem Müftüoğlu

Evaluation of the Side Effect Profile of Intracavitary Bacillus Calmette-Guérin Treatment in Non-muscle-invasive Bladder Cancer

• Şenol Tonyalı
• Mustafa Karaaslan
• Mehmet Yılmaz
• Cavit Ceylan

Influence of Primary or Secondary Muscle Invasive Bladder Cancer on Oncologic Outcomes After Radical Cystectomy

• Serdar Çelik
• Anıl Eker
• Ertuğrul Şefik
• İbrahim Halil Bozkurt
• İsmail Basmacı
• Bülent Günlüsoy
• Tansu Değirmenci

Article - Comment

Treatment delay and prognosis in invasive bladder cancer

• Sertaç Yazici

Original Articles

The Incidence of Prostate Adenocarcinoma in Patients Who Underwent Cystoprostatectomy for Invasive Baldder Cancer and Histopathological Examination

• Yasin Ceylan
• Volkan Şen
• Salih Polat
• Bülent Günlüsoy
• Tansu Değirmenci
• Yusuf Kadir Topçu
• Deniz Bolat
• Zafer Kozacıoğlu

Mycobacterium Brumae Extract Fractions with Potential Immunotherapeutic Activity for Bladder Cancer

• Zeliha Ertürk
• Esra Büber
• Haluk Özen
• Ömür Çelikbıçak
• Bekir Salih
• N. Leyla Açan

Medical Oncology

Neoadjuvant chemotherapy in muscle invasive bladder cancer

• Evren Süer
• Kadir Türkölmez